期刊文献+

短肠综合征治疗进展 被引量:2

New Clinical Management of Short Bowel Syndrome
下载PDF
导出
摘要 短肠综合征患者的治疗包括内、外科治疗。其中肠外营养在内科治疗中起着重要作用。肠外营养提供了水、电解质和必要营养物以维持生命,其同时存在致命的并发症,如感染、静脉通道破坏消失、血管栓塞及肝脏损害。这促成了一些新的治疗方法的产生,如生长因子的使用,以及为减轻症状使用的辅助药物(如奥曲肽减轻腹泻等)。外科手术主要包括肠管的倒置吻合、肠襻圈形吻合以及延长小肠长度提高小肠功能,小肠移植也得到一定的发展。 The treatments for short bowel syndrome include medical treatment and surgical treatment.Parenteral nutrition plays a crucial role in the medical treatment.Although parenteral nutrition provide water,electrolytes,and necessary nutrients essential for life maintenance,it is concomitantly complicated with life-threatening comorbidities,such as infection,destruction of venous access pathway,thrombosis,and liver injuries.This promotes the emergence of some novel treatments,including the use of growth factors and adjuvant agents to alleviate symptoms(for example,octreotide for diarrhea).Surgical treatment includes intestinal tapering,recirculating loop,and intestinal lengthening to improve the intestinal function.Intestinal transplantation has been also developed.
出处 《医学综述》 2011年第3期417-419,共3页 Medical Recapitulate
关键词 短肠综合征 治疗 小肠移植 Short bowel syndrome Management Intestinal transplantation
  • 相关文献

参考文献26

  • 1Goulet O,Joly F,Corriol O.Some new insights in intestinal failure-associated liver disease[J].Curr Opin Organ Transplant,2009,14(3):256-261. 被引量:1
  • 2O'Brien DP.Intestinal adaptation:structure,function,and regulation[J].Semin Pediatr Surg,2001,10(2):56-64. 被引量:1
  • 3Byrne TA,Morissey TB,Nattakom TV.Growth hormone,glutamine and a modified diet enhance nutritient absorption in patients with severe short bowel syndrome[J].J Parenter Enteral Nutr,1995,19(4):296-302. 被引量:1
  • 4Szkudlarek PB,Jeppesen PB.Effect of hig dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients:a randomised,double blind,crossover,placebo controlled study[J].J Gut,2000,47(2):199-205. 被引量:1
  • 5Theresa A.Growth hormone,glutamine,and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome[J].J Ann Surg,2005,242(5):655-661. 被引量:1
  • 6Rubin DC.Nutrient regulation of intestinal growth and adaptation:role of glucagon-like peptide 2 and the enteroendocrine cell[J].Gastroenterology,1999,117(1):99-105. 被引量:1
  • 7Holst JJ,Orskov C,Nielsen OV.Truncated glucagon-like peptide I,an insulin-releasing hormone from the distal gut[J].FEBS Lett,1987,211(2):169-174. 被引量:1
  • 8Holst JJ.Glucagonlike peptide I:a newly discovered gastrointestinal homone[J].Gastroenterology,1994,107(6):1848-1855. 被引量:1
  • 9Wojdemann M,Wettergren A,Hartmann B.Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs[J].Scand J Gastroenterol,1998,33(8):828-832. 被引量:1
  • 10Wojdemann M,Wettergren A,Hartmann B.Inhibition of sham feeding stimulated human gastric acid secretion by glucagon-like peptide-2[J].J Clin Endocrinal Metab,1999,84(7):2513-2517. 被引量:1

二级参考文献15

  • 1李杭,吴国豪,陈吉.胰高糖素样肽2对肠道缺血再灌注小鼠黏膜免疫变化的影响[J].中华胃肠外科杂志,2006,9(1):67-70. 被引量:6
  • 2田延锋,李勇.梗阻性黄疸对肠黏膜屏障功能的影响及药物干预[J].河北医科大学学报,2007,28(2):151-154. 被引量:9
  • 3Stephens J, Stoll B, Cottrell J, et al. Glucagon-like peptide- 2 acutely increases proximal small intestinal blood flow in TPN-fed neonatal piglets [ J ]. Am J Physiol Regul Integr Comp Physiol, 2006,290(2) : R283 -R289. 被引量:1
  • 4Wallis K, Waiters JR, Forbes A. Review article: glucagonlike peptide 2 current applications and future directions [ J ] . Aliment Pharmacol Ther, 2007,25 ( 2 ) : 365 - 372. 被引量:1
  • 5Prue MP, Eva S, Sarah LT,et al. GLP-2 administration resuits in increased proliferation but paradoxically an adverse outcome in a juvenile piglet model of short bowel syndrome [ J ] . J Pediatc Gastro and Nutri, 2008,46( 1 ) :20-28. 被引量:1
  • 6Dube PE, Brubaker PL. Frontiers in glucagon-like' peptide- 2: multiple actions, multiple mediators [ J ]. Am J Physiol Endocrinol Metab, 2007 , 293 ( 2 ) : E460 - 465. 被引量:1
  • 7Paul H, Omar E, Patricia J, et al. Regulation of myosin light chain kinase and telokin expression in smooth muscle tissues[J]. Am J Physiol Cell Physiol,2006,291(5) : 817 -827. 被引量:1
  • 8Fabeha F, Lianzhi G, Ivanna I, et al. Inhibiting myosin light chain kinase induces apoptosis in vitro and in vivo [ J ]. Mol Cel Biol, 2005, 25(14): 6259-6266. 被引量:1
  • 9Madara JL. Relationships between the tight junctions and the cytoskeleton [ A ]. In : M Cerreijido. Tight Junctions [ M ]. Boca Raton, FL: CRC, 1992:105- 120. 被引量:1
  • 10Wang F, Graham WV, Wang Y, et al. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression [ J ]. Am J Pathol, 2005, 166 (2) :409 -419. 被引量:1

共引文献2

同被引文献43

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部